(Q51064511)

English

Prognostic significance of histologic grading in patients with prostate carcinoma who are assessed by the Gleason and World Health Organization grading systems in needle biopsies obtained prior to radiotherapy.

scientific article published in July 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/11466684

Prognostic significance of histologic grading in patients with prostate carcinoma who are assessed by the Gleason and World Health Organization grading systems in needle biopsies obtained prior to radiotherapy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/11466684

Adaptive radiation therapy

0 references

World Health Organization

1 reference

based on heuristic

inferred from title

prostate carcinoma

1 reference

based on heuristic

inferred from title

Sophie D. Fosså

5

object named as

Fosså SD

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

author name string

Lilleby W

1

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/11466684

Torlakovic G

2

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/11466684

Torlakovic E

3

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/11466684

Skovlund E

4

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/11466684

language of work or name

0 references

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/11466684

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/11466684

92

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/11466684

2

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/11466684

311-319

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/11466684

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C311%3A%3AAID-CNCR1324%3E3.0.CO%3B2-H

21 January 2018

Prognostic factor research in oncology

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C311%3A%3AAID-CNCR1324%3E3.0.CO%3B2-H

21 January 2018

The effect of dose on local control of prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C311%3A%3AAID-CNCR1324%3E3.0.CO%3B2-H

21 January 2018

Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C311%3A%3AAID-CNCR1324%3E3.0.CO%3B2-H

21 January 2018

Histologic grading of prostate cancer: a perspective

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C311%3A%3AAID-CNCR1324%3E3.0.CO%3B2-H

21 January 2018

Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C311%3A%3AAID-CNCR1324%3E3.0.CO%3B2-H

21 January 2018

Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C311%3A%3AAID-CNCR1324%3E3.0.CO%3B2-H

21 January 2018

A pathologist's view of prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C311%3A%3AAID-CNCR1324%3E3.0.CO%3B2-H

21 January 2018

The correlation between the ASTRO Consensus Panel definition of biochemical failure and clinical outcome for patients with prostate cancer treated with external beam irradiation. American Society of Therapeutic Radiology and Oncology

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C311%3A%3AAID-CNCR1324%3E3.0.CO%3B2-H

21 January 2018

American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C311%3A%3AAID-CNCR1324%3E3.0.CO%3B2-H

21 January 2018

Prostatic carcinoma: a multivariate analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C311%3A%3AAID-CNCR1324%3E3.0.CO%3B2-H

21 January 2018

Accuracy of biopsy Gleason scores from a large uropathology laboratory: use of a diagnostic protocol to minimize observer variability

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C311%3A%3AAID-CNCR1324%3E3.0.CO%3B2-H

21 January 2018

Histological grading of prostatic carcinoma in prostatectomy specimens. Comparison of prognostic accuracy of five grading systems

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C311%3A%3AAID-CNCR1324%3E3.0.CO%3B2-H

21 January 2018

Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C311%3A%3AAID-CNCR1324%3E3.0.CO%3B2-H

21 January 2018

Prognostic factors for clinically localized prostate carcinoma: analysis of 938 patients irradiated in the prostate specific antigen era

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C311%3A%3AAID-CNCR1324%3E3.0.CO%3B2-H

21 January 2018

TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C311%3A%3AAID-CNCR1324%3E3.0.CO%3B2-H

21 January 2018

The relative importance of prognostic factors in studies of survival

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C311%3A%3AAID-CNCR1324%3E3.0.CO%3B2-H

21 January 2018

Grading of prostatic cancer: II. The prognostic significance of the presence of multiple architectural patterns

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C311%3A%3AAID-CNCR1324%3E3.0.CO%3B2-H

21 January 2018

Histological evaluation of prostatic cancer. (III): Reproducibility of assessment of tumour volume and its possible significance for prognosis.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C311%3A%3AAID-CNCR1324%3E3.0.CO%3B2-H

21 January 2018

Correlation of pathologic findings with progression after radical retropubic prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C311%3A%3AAID-CNCR1324%3E3.0.CO%3B2-H

21 January 2018

Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C311%3A%3AAID-CNCR1324%3E3.0.CO%3B2-H

21 January 2018

Capsular penetration in prostate cancer. Significance for natural history and treatment

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C311%3A%3AAID-CNCR1324%3E3.0.CO%3B2-H

21 January 2018

Defining clinically significant prostate cancer: pathologic criteria versus outcomes data

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C311%3A%3AAID-CNCR1324%3E3.0.CO%3B2-H

21 January 2018

Should Gleason score 7 prostate cancer be considered a unique grade category?

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C311%3A%3AAID-CNCR1324%3E3.0.CO%3B2-H

21 January 2018

Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C311%3A%3AAID-CNCR1324%3E3.0.CO%3B2-H

21 January 2018

Identifiers

10.1002/1097-0142(20010715)92:2<311::AID-CNCR1324>3.0.CO;2-H

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/11466684

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/11466684

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51064511&oldid=1505517533"